Publicly-Funded Covid-19 Treatment Paxlovid™
Paxlovid™ (nirmatrelvir/ritonavir) is an oral antiviral medication used to treat mild to moderate COVID-19 infection in adults who are at high risk of progressing to serious disease. It is intended to be used as soon as possible after diagnosis and within 5 days of symptom onset. You have to obtain a PRESCRIPTION from your physician first.
Please note that due to the complexity of Paxlovid's drug interactions with other medications, some of which may have *serious or fatal* consequences, we suggest you to pick up your Paxlovid prescription from the same pharmacy where you pick up your other regular prescriptions. We will only accept Paxlovid prescription from our own patients due to the *complexity* and *safety issues* associated with Paxlovid drug interactions.
Please contact your physician to discuss your eligibility for publicly-funded Paxlovid™:
1. A positive COVID-19 test result (PCR or rapid antigen test self-administered at home or by a healthcare professional) -AND-
2. You will be starting Paxlovid™ treatment within 5 days of symptom onset -AND-
3. One of the following factors applies to you:
a. You are 18 years of age or older and is immunocompromised
b. You are 70 years of age or older
c. You are 60 years of age or older and have received less than 3 doses of a COVID-19 vaccine
d. You are 18 years of age or older, have received less than 3 doses of COVID-19 vaccine, and have at least one of the following risk conditions:
• heart disease, hypertension, congestive heart failure
• chronic respiratory disease (including cystic fibrosis)
• cerebral palsy
• intellectual and developmental disabilities
• sickle cell disease
• moderate or severe kidney disease
• moderate or severe liver disease
• pregnant and unvaccinated (zero doses)
e. You are assessed as being at higher risk of severe COVID-19 based on your age, vaccination status, and risk conditions (excluding risks due to travel) by your prescriber.